These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3336740)

  • 1. Experimental investigations of the Hexabrix-papaverine interaction.
    McGill JE; Rysavy JA; Frick MP
    Radiology; 1988 Feb; 166(2):577-8. PubMed ID: 3336740
    [No Abstract]   [Full Text] [Related]  

  • 2. Incompatibility of Hexabrix and papaverine.
    Pilla TJ; Beshany SE; Shields JB
    AJR Am J Roentgenol; 1986 Jun; 146(6):1300-1. PubMed ID: 3486573
    [No Abstract]   [Full Text] [Related]  

  • 3. Incompatibility of Hexabrix and papaverine in peripheral arteriography.
    Shah SJ; Gerlock AJ
    Radiology; 1987 Mar; 162(3):619-20. PubMed ID: 3809473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incompatibility of Hexabrix and papaverine.
    Delcour C
    AJR Am J Roentgenol; 1986 Nov; 147(5):1096. PubMed ID: 3490158
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the vincamine-papaverine association ii. acute toxicity in experimental animals as a function of the speed of infusion.
    Nunziata A; Costrini R; Mercatelli P; Perri GC
    Agressologie; 1978; 19(3):215-9. PubMed ID: 736221
    [No Abstract]   [Full Text] [Related]  

  • 6. Incompatibility of papaverine with various intravascular contrast agents.
    Burbridge BE
    Radiology; 1993 Oct; 189(1):287. PubMed ID: 8267741
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in peripheral pulmonary vascular resistance after ioxaglate infusion in anesthetized dogs.
    Chabot F; Saunier C; Schrijen F
    Can J Physiol Pharmacol; 1997 Jan; 75(1):15-8. PubMed ID: 9101060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dose-response relationship in the use of hexabrix in angiography].
    Tatochenko KV; Kondrashin SA
    Vestn Rentgenol Radiol; 1991; (5):18-20. PubMed ID: 1799037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylaxis following "Hexabrix" during routine coronary angiography.
    Langton JA; Magee P; Sedgwick J; Sutton R
    Eur J Radiol; 1988 Feb; 8(1):60-1. PubMed ID: 3356199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of papaverine and isoproterenol in the vascular system of the dog and intestinal smooth muscle of the rabbit.
    Hansl NR; Zarlengo DG
    Clin Toxicol; 1977; 11(4):427-35. PubMed ID: 201425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and electrophysiologic effects of low osmolar contrast agents during coronary angiography in the dog and the rabbit.
    Doucet D; Idée JM; Donadieu AM; Bonnemain B
    Ann Radiol (Paris); 1989; 32(1):43-8. PubMed ID: 2742326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of papaverine on pancreatic exocrine secretion in the dog.
    Iwatsuki K; Chiba S
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):314-21. PubMed ID: 7224713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended precautions when using low-osmolality or nonionic contrast agents with vasodilators.
    Zagoria RJ; D'Souza VJ; Baker AL
    Invest Radiol; 1987 Jun; 22(6):513-4. PubMed ID: 3623855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined actions of verapamil and contrast media on atrioventricular conduction. Influence of osmolality of the media.
    Peck WW; Slutsky RA; Mancini GB; Higgins CB
    Invest Radiol; 1984; 19(3):202-7. PubMed ID: 6469525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of contrast media on myocardial function during acute left ventricular failure in the dog.
    Kløw NE; Hevrøy O; Dale K; Mjøs OD
    Invest Radiol; 1990 Jan; 25(1):41-5. PubMed ID: 2298549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructure of rabbit tracheal epithelium after the administration of Hexabrix--a hexaiodated contrast agent for tracheobronchography.
    Konrádová V; Tůma S; Kanta J; Sulová J
    Funct Dev Morphol; 1992; 2(1):31-5. PubMed ID: 1515674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the combined action of pyrilene and papaverine on the vascular system].
    Zgoda LI
    Farmakol Toksikol; 1967; 30(6):691-4. PubMed ID: 5598438
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose clinical urography with the low-osmolality contrast agent Hexabrix: comparison with a conventional contrast agent.
    Spataro RF; Katzberg RW; Fischer HW; McMannis MJ
    Radiology; 1987 Jan; 162(1 Pt 1):9-14. PubMed ID: 3538156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incompatibility of contrast agents with intravascular medications. Work in progress.
    Irving HD; Burbridge BE
    Radiology; 1989 Oct; 173(1):91-2. PubMed ID: 2781036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiation of the properties of atropine and papaverine in the same series of carbacoxy-1 ethylamino-4 piperazines].
    Pomaret JC; Sergant-Ody M; Pourrias B; Huguet G
    Therapie; 1969; 24(1):109-43. PubMed ID: 5807416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.